Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora

Microbial Pathogenesis

Volumn 48, Issue 3-4, 2010, Pages 131-142

  Mohawk, Krystle L ^a   Melton Celsa, Angela R ^a   Zangari, Tonia ^a   Carroll, Erica E ^b   O'Brien, Alison D ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

Escherichia coli O157:H7 mouse model; intimin; Shiga toxin

Indexed keywords

INTIMIN; NALIDIXIC ACID; NITROGEN; UREA; VEROTOXIN 2; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; AUTOPSY; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL STRAIN; BAGG ALBINO MOUSE; COLONY FORMING UNIT; COMMENSAL; CONTROLLED STUDY; DEATH; DISEASE MODEL; ESCHERICHIA COLI O157; FEMALE; INOCULATION; INTESTINE FLORA; KIDNEY TUBULE DAMAGE; MOUSE; MOUTH INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL; WEIGHT REDUCTION;

ADHESINS, BACTERIAL; ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FECES; FEMALE; GASTROINTESTINAL TRACT; GENE EXPRESSION PROFILING; HUMANS; KIDNEY TUBULES; MICE; MICE, INBRED BALB C; SHIGA TOXIN 2; SURVIVAL ANALYSIS; UREA; VIRULENCE FACTORS;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS;

EID: 77649185394     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2010.01.003     Document Type: Article

References (51)

1. Mead P.S., Slutsker L., Dietz V., McCaig L.F., Bresee J.S., Shapiro C., et al. Food-related illness and death in the United States. Emerg Infect Dis 5 (1999) 607-625
2. Rangel J.M., Sparling P.H., Crowe C., Griffin P.M., and Swerdlow D.L. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg Infect Dis 11 (2005) 603-609
3. Manning S.D., Motiwala A.S., Springman A.C., Qi W., Lacher D.W., Ouellette L.M., et al. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci U S A 105 (2008) 4868-4873
4. CDC. Update on multi-state outbreak of E. coli O157:H7 infections from fresh spinach, October 6, 2006. E coli O157:H7 Outbreak from Fresh Spinach; 2006.
5. Brandt M.L., O'Regan S., Rousseau E., and Yazbeck S. Surgical complications of the hemolytic-uremic syndrome. J Pediatr Surg 25 (1990) 1109-1112
6. Mead P.S., and Griffin P.M. Escherichia coli O157:H7. Lancet 352 (1998) 1207-1212
7. Tilden Jr. J., Young W., McNamara A.M., Custer C., Boesel B., Lambert-Fair M.A., et al. A new route of transmission for Escherichia coli: infection from dry fermented salami. Am J Public Health 86 (1996) 1142-1145
8. Foster J.W. Escherichia coli acid resistance: tales of an amateur acidophile. Nat Rev Microbiol 2 (2004) 898-907
9. Garmendia J., Frankel G., and Crepin V.F. Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect Immun 73 (2005) 2573-2585
10. O'Brien A.O., Lively T.A., Chen M.E., Rothman S.W., and Formal S.B. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin. Lancet 1 (1983) 702
11. Karmali M.A., Steele B.T., Petric M., and Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1 (1983) 619-620
12. Karmali M.A., Petric M., Lim C., Fleming P.C., Arbus G.S., and Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151 (1985) 775-782
13. Pai C.H., Gordon R., Sims H.V., and Bryan L.E. Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features. Ann Intern Med 101 (1984) 738-742
14. Obrig T.G. Shiga toxin mode of action in E. coli O157:H7 disease. Front Biosci 2 (1997) d635-d642
15. Obrig T.G., Louise C.B., Lingwood C.A., Boyd B., Barley-Maloney L., and Daniel T.O. Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 268 (1993) 15484-15488
16. Ohmi K., Kiyokawa N., Takeda T., and Fujimoto J. Human microvascular endothelial cells are strongly sensitive to Shiga toxins. Biochem Biophys Res Commun 251 (1998) 137-141
17. Richardson S.E., Karmali M.A., Becker L.E., and Smith C.R. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 19 (1988) 1102-1108
18. Ergonul Z., Clayton F., Fogo A.B., and Kohan D.E. Shigatoxin-1 binding and receptor expression in human kidneys do not change with age. Pediatr Nephrol 18 (2003) 246-253
19. Melton-Celsa A.R., and O'Brien A.D. Animal models for STEC-mediated disease. Methods Mol Med 73 (2003) 291-305
20. Isogai E., Isogai H., Kimura K., Hayashi S., Kubota T., Fujii N., et al. Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain. Infect Immun 66 (1998) 197-202
21. Aiba Y., Ishikawa H., Shimizu K., Noda S., Kitada Y., Sasaki M., et al. Role of internalization in the pathogenicity of Shiga toxin-producing Escherichia coli infection in a gnotobiotic murine model. Microbiol Immunol 46 (2002) 723-731
22. Kurioka T., Yunou Y., and Kita E. Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infect Immun 66 (1998) 1726-1734
23. Shimizu K., Asahara T., Nomoto K., Tanaka R., Hamabata T., Ozawa A., et al. Development of a lethal Shiga toxin-producing Escherichia coli-infection mouse model using multiple mitomycin C treatment. Microb Pathog 35 (2003) 1-9
24. Zhang X., McDaniel A.D., Wolf L.E., Keusch G.T., Waldor M.K., and Acheson D.W. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis 181 (2000) 664-670
25. Lindgren S.W., Melton A.R., and O'Brien A.D. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect Immun 61 (1993) 3832-3842
26. Sperandio V., Mellies J.L., Nguyen W., Shin S., and Kaper J.B. Quorum sensing controls expression of the type III secretion gene transcription and protein secretion in enterohemorrhagic and enteropathogenic Escherichia coli. Proc Natl Acad Sci U S A 96 (1999) 15196-15201
27. Wadolkowski E.A., Sung L.M., Burris J.A., Samuel J.E., and O'Brien A.D. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun 58 (1990) 3959-3965
28. Karpman D., Connell H., Svensson M., Scheutz F., Alm P., and Svanborg C. The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J Infect Dis 175 (1997) 611-620
29. Kang G., Pulimood A.B., Koshi R., Hull A., Acheson D., Rajan P., et al. A monkey model for enterohemorrhagic Escherichia coli infection. J Infect Dis 184 (2001) 206-210
30. Garcia A., Bosques C.J., Wishnok J.S., Feng Y., Karalius B.J., Butterton J.R., et al. Renal injury is a consistent finding in Dutch Belted rabbits experimentally infected with enterohemorrhagic Escherichia coli. J Infect Dis 193 (2006) 1125-1134
31. Ruggenenti P., Noris M., and Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 60 (2001) 831-846
32. Chaisri U., Nagata M., Kurazono H., Horie H., Tongtawe P., Hayashi H., et al. Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome. Microb Pathog 31 (2001) 59-67
33. Takeda T., Dohi S., Igarashi T., Yamanaka T., Yoshiya K., and Kobayashi N. Impairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uraemic syndrome. J Infect 27 (1993) 339-341
34. Kaneko K., Kiyokawa N., Ohtomo Y., Nagaoka R., Yamashiro Y., Taguchi T., et al. Apoptosis of renal tubular cells in Shiga-toxin-mediated hemolytic uremic syndrome. Nephron 87 (2001) 182-185
35. Tesh V.L., Burris J.A., Owens J.W., Gordon V.M., Wadolkowski E.A., O'Brien A.D., et al. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61 (1993) 3392-3402
36. Nagano K., Taguchi K., Hara T., Yokoyama S., Kawada K., and Mori H. Adhesion and colonization of enterohemorrhagic Escherichia coli O157:H7 in cecum of mice. Microbiol Immunol 47 (2003) 125-132
37. Knutton S., Adu-Bobie J., Bain C., Phillips A.D., Dougan G., and Frankel G. Down regulation of intimin expression during attaching and effacing enteropathogenic Escherichia coli adhesion. Infect Immun 65 (1997) 1644-1652
38. Cornick N.A., Matise I., Samuel J.E., Bosworth B.T., and Moon H.W. Shiga toxin-producing Escherichia coli infection: temporal and quantitative relationships among colonization, toxin production, and systemic disease. J Infect Dis 181 (2000) 242-251
39. Matise I., Cornick N.A., Booher S.L., Samuel J.E., Bosworth B.T., and Moon H.W. Intervention with Shiga toxin (Stx) antibody after infection by Stx-producing Escherichia coli. J Infect Dis 183 (2001) 347-350
40. Yamagami S., Motoki M., Kimura T., Izumi H., Takeda T., Katsuura Y., et al. Efficacy of postinfection treatment with anti-Shiga toxin (Stx) 2 humanized monoclonal antibody TMA-15 in mice lethally challenged with Stx-producing Escherichia coli. J Infect Dis 184 (2001) 738-742
41. Sheoran A.S., Chapman-Bonofiglio S., Harvey B.R., Mukherjee J., Georgiou G., Donohue-Rolfe A., et al. Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications. Infect Immun 73 (2005) 4607-4613
42. Conlan J.W., and Perry M.B. Susceptibility of three strains of conventional adult mice to intestinal colonization by an isolate of Escherichia coli O157:H7. Can J Microbiol 44 (1998) 800-805
43. Judge N.A., Mason H.S., and O'Brien A.D. Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces. Infect Immun 72 (2004) 168-175
44. Karpman D.O. Studies of the pathogenesis of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Medical Microbiology and Pediatrics (1997), Lund University, Lund p. 179
45. Fujii Y., Numata S., Nakamura Y., Honda T., Furukawa K., Urano T., et al. Murine glycosyltransferases responsible for the expression of globo-series glycolipids: cDNA structures, mRNA expression, and distribution of their products. Glycobiology 15 (2005) 1257-1267
46. National Institute of Health and Infectious Disease Control Division MoHaWoJ. Outbreaks of enterohemorrhagic Escherichia coli O157:H7 infection, 1996, Japan. Infect Agents Surveill Rep (1996) 180-181
47. Griffin P.M., Ostroff S.M., Tauxe R.V., Greene K.D., Wells J.G., Lewis J.H., et al. Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med 109 (1988) 705-712
48. Gansheroff L.J., Wachtel M.R., and O'Brien A.D. Decreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin. Infect Immun 67 (1999) 6409-6417
49. Kokai-Kun J.F., Melton-Celsa A.R., and O'Brien A.D. Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d. J Biol Chem 275 (2000) 3713-3721
50. Neumann M., and Gabel D. Simple method for reduction of autofluorescence in fluorescence microscopy. J Histochem Cytochem 50 (2002) 437-439
51. Harlow E., and Lane D. Antibodies: a laboratory manual (1988), Cold Spring Harbor Laboratory, Cold Spring Harbor